Professional Documents
Culture Documents
The Novel Coronavirus (SARS-CoV-2) FAST Nucleic Acid Detection Kit is developed for qualitative detection of SARS-CoV-2 that is
collected from human oropharyngeal swabs in vitro. The applicable population includes: suspected cases of Novel Coronavirus
(SARS-CoV-2) infected pneumonia, suspected aggregated cases, and other patients who need to be diagnosed or differentiated with
Novel Coronavirus (SARS-CoV-2) infection.
Product Performance
● Immediately detectable: It’s easy to operate, without extraction, and only needs a fluorescence quantitative PCR instrument, The
number of samples in a single test can be adjusted flexibly according to the number of people to be tested, which is extremely suitable
for epidemic screening in communities, stations, airports, customs, supermarkets, schools and other areas.
● High sensitivity: The minimum detection limit can be as low as 200 copies / ml.
● Fast: Complete the whole process from sampling to detection in 40 minutes.
● Transportation at room temperature : The kit can be stored at room temperature and non-cold chain to minimize the shipping cost.
Detection Process
1. Collect the sample 2. Put the head of swab into 3. Take the mixed liquid and down 4. Put tube into the qPCR
with a nasal or the virus sampling tube, shake and mix well amplification tube instrument for detection and
pharyngeal swab it up and down and mix well (the Reaction Lyophilized Powder determination of the result
Dissolvent has been added)
Package 48tests/box,96tests/box,
Detection Methods PCR-Fluorescence Probing
Detect Genes ORF1ab,N
Sample Requirements Pharyngeal swab, Nasal swab, Nasopharyngeal swab
Instrument Compatibility ABI 7500,Bio-rad CFX 96, Tianlong Gentier 96, Lepgen 96, MA-6000 , etc.
There is no cross-reactivity with positive samples such as coronavirus
(NL63, HKU1, 229E, OC43), MERS-coronavirus,SARS-coronavirus,
Specificity
influenza A virus, influenza B virus Yamagata type, etc.
The negative control of the testing enterprises are all negative.
Sensitivity Minimum detection limit: 200 copies /ml
Precision The coefficient of variation (CV, %) of the precision Ct value within the batch was ≤5%.
Storage Condition Store at room temperature, before the kit is opened and used.
Valid Period 12 months
Order Information
Catalog No. Product Name Specification Package Package Size
The Novel Coronavirus (SARS-CoV-2) FAST Nucleic Acid Detection Kit is developed for qualitative detection of SARS-CoV-2 that is
collected from human oropharyngeal swabs in vitro. The applicable population includes: suspected cases of Novel Coronavirus
(SARS-CoV-2) infected pneumonia, suspected aggregated cases, and other patients who need to be diagnosed or differentiated with
Novel Coronavirus(SARS-CoV-2) infection.
Product Performance
● High sensitivity: The minimum detection limit can be as low as 200 copies / ml.
● Fast: The whole amplification process takes less than 50 minutes.
● Transportation at room temperature: The kit can be stored at room temperature and non-cold chain to minimize the shipping cost.
Order Information
Catalog No. Product Name Specification Package Package Size
Novel Coronavirus (SARS-CoV-2)
Fast Nucleic Acid Detection Kit 48tests/box
CW3130M-NP 110boxes/carton 560×420×500mm
(PCR-Fluorescence Probing) 96tests/box
(Lyophilized,required extraction)
The Novel Coronavirus (SARS-CoV-2) Nucleic Acid Detection Kit is developed for qualitative detection of SARS-CoV-2 that is
collected from human oropharyngeal swabs in vitro. The applicable population includes: suspected cases of Novel Coronavirus
(SARS-CoV-2) infected pneumonia, suspected aggregated cases, and other patients who need to be diagnosed or differentiated with
Novel Coronavirus (SARS-CoV-2) infection.
Order Information
Catalog No. Product Name Specification
The SARS-Cov-2 & Influenza A/B Nucleic Acid Test is a multiplex real-time RT-PCR assay intended for simultaneous qualitative detection
and differentiation of SARS-CoV-2, influenza A, and influenza B virus RNA in upper or lower respiratory specimens (such as
nasopharyngeal and oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal
wash/aspirate or nasal aspirate) collected from individuals suspected of respiratory viral infection consistent with SARS-CoV-2, IAV or IBV
by their healthcare provider. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2, IAV or IBV can be similar.
Product Performance
● Immediate: Easy to operate. Extracted RNA is used as a template to carry out the amplification.
● Ultrasensitive: The minimum 2019-nCoV detection limit is 200 copies/mL, and that of IAV/IBV 500 copies/mL.
● Fast: From sampling to detection, the whole process lasts only 40 minutes.
● Temperature: All components of the kit can be transported at room temperature and stored at 2-8°C.
Order Information
Catalog No. Product Name Specification
48tests/box
CW3136 SARS-CoV-2 & Influenza A/B Nucleic Acid Test(Lyophilized) 96tests/box
960tests/box